Please login to the form below

Not currently logged in
Email:
Password:

Thousands more seek lung cancer tests thanks to campaign

Be Clear on Cancer campaign coincided with 3,000 extra GP referrals

A campaign urging people with a persistent cough to visit a doctor has seen a surge of early stage lung cancer diagnoses.

During the period the Be Clear on Cancer campaign was rolled out around 700 extra patients were diagnosed with lung cancer and nearly 300 more received surgery. The campaign urged people who have been coughing for three weeks to see a doctor.

Over 3,000 extra referrals were made by GPs, up 30%, between May and July 2012 according to campaign results analysis led by Cancer Research UK and published in the British Journal of Cancer.

be clear on cancer lung campaign 

Harpal Kumar, Cancer Research UK's chief executive, said: “This proves just how successful a simple campaign alerting people to be vigilant about persistent coughing can be. The sooner people recognise changes in their bodies and go to their GP for a check-up, the better their chances if it does turn out to be cancer.

“Earlier diagnosis combined with pioneering research means we can make real progress in treating lung cancer – a devastating disease that has killed millions of people.”

A survey of 1,100 people conducted following the campaign showed that, when prompted, 33% were aware that a cough lasting more than three weeks was a lung cancer symptom, compared to 18% prior to the campaign.

Dr Mick Peake, lung cancer expert, consultant in respiratory medicine at the University of Hospitals of Leicester and lead author of the paper, said: “We were surprised to see so many more patients diagnosed with lung cancer at an early stage of their disease and then to see than being translated into a significant increase in the number of patients going on to have potentially curative surgery is hugely encouraging.

“If maintained, this effect could really result in a fall in the number of patients who die from lung cancer in the longer term.”

9th December 2014

From: Marketing, Healthcare

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Frontera Group

Welcome to Frontera Group where our agencies immerse you into the world of the patient....

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics